Aridol Bronchial Challenge Test Kit
Product Images NDC 67850-552

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Aridol Bronchial Challenge Test Kit (NDC 67850-552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Methapharm, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aridol-kit-1 (Aridol Kit 1)

Chemical structure diagram of mannitol, the active ingredient in the Aridol Bronchial Challenge Test Kit by Methapharm, Inc. The structure shows the molecular connectivity and stereochemistry of mannitol.*

FDA Label Image

Aridol Kit 2

Packaging label for Aridol Bronchial Challenge Test Kit containing mannitol inhalation powder. The kit is intended for oral inhalation use to measure bronchial hyperresponsiveness. The label shows contents including 3 blister cards with capsules of various mannitol doses (0 mg, 5 mg, 10 mg, 20 mg, and 40 mg) and one Aridol device for use with enclosed capsules. It features the labeler Methapharm, Inc., the NDC 67850-552, and branding by Pharmaxis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.